Neftaly Heart Failure Treatment Guidelines: Delivering Standardized, Evidence-Based Care
Heart failure is a complex, progressive condition that affects millions globally and remains a leading cause of hospitalizations and mortality. To support healthcare providers in delivering consistent, high-quality care, Neftaly offers comprehensive Heart Failure Treatment Guidelines—grounded in the latest clinical evidence, customizable to various care settings, and designed to improve patient outcomes across the continuum of care.
A Standardized Approach to a Complex Condition
Heart failure management requires a multifaceted, patient-centered approach that evolves with disease progression. Neftaly’s guidelines provide structured support across every stage—from diagnosis and risk stratification to treatment optimization and long-term management.
Our goal: Reduce variability in care, enhance provider confidence, and empower patients to live better with heart failure.
Key Components of Neftaly’s Heart Failure Treatment Guidelines
✅ 1. Accurate Diagnosis and Classification
- Identification of heart failure with preserved (HFpEF), reduced (HFrEF), or mildly reduced ejection fraction (HFmrEF)
- Standardized use of diagnostic tools: echocardiography, BNP/NT-proBNP testing, ECG, and chest X-ray
- Risk assessment models to guide treatment urgency
✅ 2. Pharmacological Therapy
- Evidence-based medication algorithms, including:
- ACE inhibitors / ARBs / ARNI
- Beta-blockers
- Mineralocorticoid receptor antagonists (MRAs)
- SGLT2 inhibitors
- Diuretics for symptom relief
- Dosage titration protocols and monitoring guidelines
- Guidance on deprescribing and medication reconciliation
✅ 3. Non-Pharmacologic Management
- Dietary recommendations (low sodium, fluid management)
- Exercise and cardiac rehabilitation guidelines
- Smoking cessation and alcohol moderation support
- Patient education strategies to promote self-monitoring and symptom awareness
✅ 4. Device and Advanced Therapies
- Criteria for referral to electrophysiology or heart failure specialists
- Indications for:
- Implantable cardioverter defibrillators (ICDs)
- Cardiac resynchronization therapy (CRT)
- Mechanical circulatory support (LVADs)
- Heart transplantation evaluation
✅ 5. Transitions of Care & Follow-Up
- Structured discharge planning and post-hospital follow-up protocols
- Use of telemonitoring, home visits, and virtual check-ins
- Medication reconciliation and early intervention for decompensation
✅ 6. End-of-Life and Palliative Considerations
- Early integration of palliative care for symptom control
- Shared decision-making tools for advanced care planning
- Guidance on hospice referral when appropriate
Digital Integration with Neftaly
Neftaly’s guidelines are embedded in our clinical decision support platform and electronic workflows to ensure seamless integration at the point of care:
- Real-time alerts and treatment prompts
- Checklists and order sets aligned with the latest ACC/AHA/HFSA guidelines
- Patient education materials automatically generated based on diagnosis and treatment plan
- Population health analytics to identify care gaps and optimize outcomes
Benefits of Neftaly’s Heart Failure Treatment Guidelines
- Consistency in care delivery across providers and settings
- Confidence for clinicians through real-time, evidence-backed support
- Improved outcomes through timely interventions and adherence to proven therapies
- Reduced readmissions and enhanced patient engagement
- Support for value-based care models and quality reporting metrics
Partner with Neftaly to Standardize and Strengthen Heart Failure Care
Neftaly’s Heart Failure Treatment Guidelines empower healthcare teams with the tools and insights they need to deliver high-quality, guideline-directed care every time. Whether you’re a primary care provider, cardiologist, or care coordinator, Neftaly ensures you’re supported in every step of the patient journey.


